Template:Appendicitis Antibiotics: Difference between revisions

No edit summary
 
Line 21: Line 21:


'''Options:'''
'''Options:'''
*[[Metronidazole]] 50mg IV q8hrs +
*[[Metronidazole]] 500 mg IV q8hrs +
**[[Cefepime]] 50mg/kg IV q12hrs OR
**[[Cefepime]] 50 mg/kg IV q12hrs OR
**[[Ciprofloxacin]] 400mg IV q12hrs OR
**[[Ciprofloxacin]] 400 mg IV q12hrs OR
**[[Levofloxacin]] 750mg IV q24hrs OR
**[[Levofloxacin]] 750 mg IV q24hrs OR
**[[Aztreonam]] 30mg/kg IV q8hrs
**[[Aztreonam]] 30 mg/kg IV q8hrs
*[[Imipenem/Cilastatin]] 25mg/kg IV q6hrs (max 500mg)
*[[Imipenem/Cilastatin]] 25 mg/kg IV q6hrs (max 500mg)
*[[Meropenem]] 20mg/kg IV q8hrs (max 1g)
*[[Meropenem]] 20 mg/kg IV q8hrs (max 1g)
*[[Piperacillin/Tazobactam]] 100mg/kg (max 4.5g) IV q8hrs
*[[Piperacillin/Tazobactam]] 100 mg/kg (max 4.5g) IV q8hrs
''Cautious use should be applied to use of [[fluoroquinolones]] in complicated pediatric appendicitis due to the risk of tendon injury''
''Cautious use should be applied to use of [[fluoroquinolones]] in complicated pediatric appendicitis due to the risk of tendon injury''

Latest revision as of 16:08, 30 November 2018

Coverage should extend to E. coli, Klebsiella, Proteus, and Bacteroides (an anaerobe)

Adult Simple Appendicitis

Antibiotic prophylaxis should be coordinated with surgical consult

Options:

Pediatric Simple Appendicitis

Options:

Complicated Appendicitis

Defined as perforation, abscess, or phlegmon

Options:

Cautious use should be applied to use of fluoroquinolones in complicated pediatric appendicitis due to the risk of tendon injury